REFERENCES
- Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton
AE, Josephson ME, Zimetbaum PJ, Mitchell SL, Reynolds MR. Mortality
risk following replacement implantable cardioverter-defibrillator
implantation at end of battery life: Results from the NCDR.Heart Rhythm . 2014 Feb:11(2):216-221. PMID: 24513917.
- Merchant FM, Quest T, Leon AR, El-Chami MF. Implantable
Cardioverter-Defibrillators at End of Battery Life: Opportunities for
Risk (Re)-Stratification in ICD Recipients. J Am Coll Cardiol .
2016 Feb;67(4):435-444. PMID: 26821633.
- Smer A, Saurav A, Azzouz MS, Salih M, Ayan M, Abuzaid A, Akinapelli A,
Kanmanthareddy A, Rosenfeld LE, Merchant FM, Abuissa H. Meta-analysis
of Risk of Ventricular Arrhythmias After Improvement in Left
Ventricular Ejection Fraction During Follow-Up in Patients with
Primary Prevention Implantable Cardioverter Defibrillators. Am J
Cardiol . 2017 Jul 15;120(2):279-286. PMID: 28532779.
- Adabag S, Anand V, Gutierrez A. (2019) ‘Replacement of implantable
cardioverter-defibrillators when ventricular function has recovered’,
in Steinberg JS, Epstein AE (eds.) Clinical Controversies in
Device Therapy for Cardiac Arrhythmias . Springer, pp. 101-114
- Chang DD, Pantlin PG, Benn FA, Gullatt TR, Bernard ML, Hiltbold AE,
Khatib S, Polin GM, Rogers PA, Velasco-Gonzalez C, Morin DP. Risk of
ventricular arrhythmias following implantable
cardioverter-defibrillator generator change in patients with recovered
ejection fraction: Implications for shared decision making. J
Cardiovasc Electrophysiol. 2023
- Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA,
Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ.
Outcomes After Implantable Cardioverter-Defibrillator Generator
Replacement for Primary Prevention of Sudden Cardiac Death. Circ
Arrhythm Electrophysiol . 2016 Mar;9(3):e003283. PMID: 26921377.
- Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy
WC, Poole JE. Association of Implantable Cardioverter Defibrillators
With Survival in Patients With and Without Improved Ejection Fraction:
Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.JAMA Cardiol . 2017 Jul;2(7):767-774. PMID: 28724134.
- Adabag S, Langsetmo L. Sudden cardiac death risk prediction in heart
failure with preserved ejection fraction. Heart Rhythm . 2020
Mar;17(3):358-364. doi: 10.1016/j.hrthm.2019.12.009. Epub 2019 Dec 13.
PubMed PMID: 31838199
- Kalver E, Branch-Elliman W, Stolzmann K, Wachterman M, Shin MH,
Schweizer ML, Mull HJ. Prevalence of one-year mortality after
implantable cardioverter defibrillator placement: An opportunity for
palliative care. J Palliat Med. 2023 Feb;26(2):175-181
- Adabag S, Vo TN, Langsetmo L, Schousboe JT, Cawthon PM, Stone KL,
Shikany JM, Taylor BC, Ensrud KE. Frailty as a Risk Factor for
Cardiovascular Versus Noncardiovascular Mortality in older men:
Results from the MrOS Sleep (Outcomes of Sleep Disorders in Older Men)
Study. J Am Heart Assoc . 2018 May;7(10). PMID: 29728373.
- Anantha Narayanan M, Vakil K, Reddy YN, Baskaran J, Deshmukh A,
Benditt DG, Adabag S. Efficacy of Implantable
Cardioverter-Defibrillator Therapy in Patients With Nonischemic
Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized
Controlled Trials. JACC Clin Electrophysiol . 2017
Sep;3(9):962-970. PMID: 29759721.